Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine A Sugarman

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Drugs & Aging|November 10, 2016
Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with PolypharmacyElaine A Sugarman, Ali Cullors, Joel Centeno, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 17, 2004
CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populationsElaine A Sugarman, Elizabeth M Rohlfs, Lawrence M Silverman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 17, 2004
Analysis of 3208 cystic fibrosis prenatal diagnoses: impact of carrier screening guidelines on distribution of indications for CFTR mutation and IVS-8 poly(T) analysesElizabeth M Rohlfs, Vivian J Weinblatt, Karen J Treat, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 16, 2011
Technical standards and guidelines for spinal muscular atrophy testingThomas W Prior, Narasimhan Nagan, Elaine A Sugarman, et al.
Pharmacogenomics and Personalized Medicine|February 9, 2016
Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facilityJuan-Sebastian Saldivar, David Taylor, Elaine A Sugarman, et al.
Journal of Assisted Reproduction and Genetics|October 25, 2017
At the dawn of personalized reproductive medicine: opportunities and challenges with incorporating multigene panel testing into fertility carePiraye Yurttas Beim, David-Emlyn Parfitt, Lei Tan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 24, 2002
The I148T CFTR allele occurs on multiple haplotypes: a complex allele is associated with cystic fibrosisElizabeth M Rohlfs, Zhaoqing Zhou, Elaine A Sugarman, et al.
Journal of Genetic Counseling|September 10, 2013
Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic CounselorsElinor Langfelder-Schwind, Barbara Karczeski, Michelle N Strecker, et al.
European Journal of Human Genetics : EJHG|August 4, 2011
Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimensElaine A Sugarman, Narasimhan Nagan, Hui Zhu, et al.
Clinical Chemistry|April 9, 2011
Cystic fibrosis carrier testing in an ethnically diverse US populationElizabeth M Rohlfs, Zhaoqing Zhou, Ruth A Heim, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Drugs & Aging|November 10, 2016
Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with PolypharmacyElaine A Sugarman, Ali Cullors, Joel Centeno, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 17, 2004
CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populationsElaine A Sugarman, Elizabeth M Rohlfs, Lawrence M Silverman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 17, 2004
Analysis of 3208 cystic fibrosis prenatal diagnoses: impact of carrier screening guidelines on distribution of indications for CFTR mutation and IVS-8 poly(T) analysesElizabeth M Rohlfs, Vivian J Weinblatt, Karen J Treat, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 16, 2011
Technical standards and guidelines for spinal muscular atrophy testingThomas W Prior, Narasimhan Nagan, Elaine A Sugarman, et al.
Pharmacogenomics and Personalized Medicine|February 9, 2016
Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facilityJuan-Sebastian Saldivar, David Taylor, Elaine A Sugarman, et al.
Journal of Assisted Reproduction and Genetics|October 25, 2017
At the dawn of personalized reproductive medicine: opportunities and challenges with incorporating multigene panel testing into fertility carePiraye Yurttas Beim, David-Emlyn Parfitt, Lei Tan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 24, 2002
The I148T CFTR allele occurs on multiple haplotypes: a complex allele is associated with cystic fibrosisElizabeth M Rohlfs, Zhaoqing Zhou, Elaine A Sugarman, et al.
Journal of Genetic Counseling|September 10, 2013
Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic CounselorsElinor Langfelder-Schwind, Barbara Karczeski, Michelle N Strecker, et al.
European Journal of Human Genetics : EJHG|August 4, 2011
Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimensElaine A Sugarman, Narasimhan Nagan, Hui Zhu, et al.
Clinical Chemistry|April 9, 2011
Cystic fibrosis carrier testing in an ethnically diverse US populationElizabeth M Rohlfs, Zhaoqing Zhou, Ruth A Heim, et al.
Pageof 2